Francis Lidgey
Director/Board Member at Phibex Plc
Francis Lidgey active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Oxford Brookes University | Corporate Officer/Principal | 1991-12-31 | - |
| Phibex Plc | Director/Board Member | - | - |
Career history of Francis Lidgey
Former positions of Francis Lidgey
| Companies | Position | Start | End |
|---|---|---|---|
| NUFORMIX PLC | Director/Board Member | - | 2020-01-30 |
| Independent Dir/Board Member | - | 2020-01-30 | |
| LTP Electronics Ltd. | Director/Board Member | - | - |
Nuformix Technologies Ltd.
 Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Nuformix Technologies Ltd. engages in investment in pharmaceutical products. Its activities include development and discovery of patented novel cocrystal forms of approved small molecules, creating an IP portfolio containing 14 granted patents covering cocrystal forms of five small molecule drugs. It offers the NXP001 and NXP002. The company was founded by Dr. David Joszef Tapolzcay and Dr. Daniel Gooding on October 23, 2007 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | - | - |
Levrett Plc
 Levrett Plc BiotechnologyHealth Technology Levrett Plc is a special purpose acquisition company. It is formed to acquire realizable and/or developed commercial technologies focused in the pharmaceutical and biotechnology sector. The company was founded on June 10, 2015 and is headquartered in London, the United Kingdom. | Chairman | - | - |
Training of Francis Lidgey
| The University of Newcastle | Doctorate Degree |
| University of Surrey | Doctorate Degree |
Statistics
International
| United Kingdom | 8 |
| Australia | 2 |
Operational
| Director/Board Member | 4 |
| Doctorate Degree | 2 |
| Chairman | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| NUFORMIX PLC | Health Technology |
| Private companies | 4 |
|---|---|
Nuformix Technologies Ltd.
Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Nuformix Technologies Ltd. engages in investment in pharmaceutical products. Its activities include development and discovery of patented novel cocrystal forms of approved small molecules, creating an IP portfolio containing 14 granted patents covering cocrystal forms of five small molecule drugs. It offers the NXP001 and NXP002. The company was founded by Dr. David Joszef Tapolzcay and Dr. Daniel Gooding on October 23, 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Levrett Plc
Levrett Plc BiotechnologyHealth Technology Levrett Plc is a special purpose acquisition company. It is formed to acquire realizable and/or developed commercial technologies focused in the pharmaceutical and biotechnology sector. The company was founded on June 10, 2015 and is headquartered in London, the United Kingdom. | Health Technology |
| Phibex Plc | |
| LTP Electronics Ltd. |
- Stock Market
- Insiders
- Francis Lidgey
- Experience
